|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3300 | Drugs / Medical | 04/12/2004
Kahn Gauthier Swick is investigating claims that the St. Jude Symmetry Bypass Aortic Connector has been associated with a high occurrence of heart attacks, respiratory failure, and has been linked several deaths. The adverse effects associated with the St. Jude Symmetry Aortic Connector include graft narrowing, valve leakage, failed deployment, and occlusion. If you or a loved one has received a St. Jude Symmetry Aortic Connector, please contact Kahn Gauthier for more information.
The St. Jude Symmetry is commonly used in "beating heart" or "off machine" heart bypass surgery. This type of bypass surgery has become increasingly popular because it eliminates the need for the bypass patient to hooked up to a lung machine during bypass surgery. The St. Jude device allows thoracic surgeons to attach saphenous (leg) vein grafts to the aorta without sutures and without clamping the aorta during the procedure. The St. Jude Medical device is one part of a system comprised of an aortic cutter, a delivery system and the connector. After an abbreviated approval process allowed by law, the U.S. Food and Drug Administration approved the St. Jude Medical device in 2001, for use in the United States. There have been thousands of the devices implanted during coronary bypass surgery, mostly in "off pump" or "beating heart" procedures where surgeons do not place the patient on the heart lung machine. Despite adverse reports, the manufacturer of the symmetric bypass aortic connectors, St. Jude Medical, neither conducted clinical trials or testing of a larger segment of the post-cardiac bypass population, nor have they made any alterations in design or manufacture that would lessen the great danger the aortic connector poses to implant patients. To make matters worse, St. Jude Medical has allegedly not contacted the physicians or patients to emphasize the importance of regular monitoring and testing of patients with the Symmetry connector. The Symmetry Bypass Aortic connector is still on the market and aggressively marketed by St. Jude Medical. The FDA began receiving reports of failure-- Many of the symmetry bypass aortic connector patients had to undergo a second, repeat coronary bypass procedure to redo the graft and remove the aortic connector device. Many suffered adverse medical events, such as heart attacks, respiratory failure, possibly even death. Kahn Gauthier Swick intends to pursue litigation of disability and death cases on behalf of symmetric bypass aortic connector device patients whose disability or death were caused by failed aortic connectors. Register your St Jude Medical ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for St Jude Medical, or click the red "submit" button on this page, and a lawyer will review your St Jude Medical complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest An Indiana man is suing Sisters of St. Francis Health Services over an incident in which the personal information of more than 200,000 patients was misplaced. The parties have reached a tentative $4.5 million settlement in several actions filed against PHP Healthcare Corporation and certain of its officers and directors by stockholders who purchased the company's common stock between July 27, 1995, and November 19, 1998. Persons eligible to participate in the settlement must file a proof of claim postmarked no later than May 13, 2004. The FDA and Boston Scientific notified patients and healthcare professionals about serious adverse events, including death, occurring in patients treated with Enteryx, a liquid chemical polymer which is intended to be injected into the lower esophageal sphincter for treatment of gastroesophageal reflux disease. The parties have reached a tentative $1.25 million settlement in a class action filed against MiniMed, Inc., and certain of its officers and directors by stockholders who held the company's common stock as of July 16, 2001. Persons eligible to participate in the settlement must submit a proof of claim form postmarked no later than September 13, 2004. What good is insurance if it doesn’t pay up when you need it? The parties have reached a $20 million settlement in an action filed against Midwestern insurance company Central States Health and Life Company of Omaha on behalf of cancer patients and their families who alleged that the company refused to pay for certain treatments allegedly covered under cancer insurance policies it sold, in violation of its contracts with the patients. Persons eligible to take part in the settlement should contact class counsel for more information. Kahn Gauthier Swick is investigating possible legal actions against EndoVascular Technologies, Inc., a wholly-owned subsidiary of medical device manufacturer Guidant Corporation, on behalf of persons who were implanted with EndoVascular's Ancure Endograft System, which is used to repair abdominal aorta aneurysms. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
